Navigation Links
Study finds 'rescue course' of antenatal steroids improves outcome in premature babies
Date:1/29/2009

WASHINGTON, DC In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, researchers will unveil findings that show that premature babies born before 34 weeks have a 31 percent reduction in serious complications when given a "rescue course" of Antenatal Corticosteroids (ACS) steroids with no adverse side effects noted.

"Premature babies are very susceptible to respiratory problems which may lead to additional severe complications," said Dr. James Kurtzman, M.D. (Associate Professor, UC Irvine Medical Center). "Antenatal steroids clearly reduce the risk of these respiratory complications."

Years ago doctors gave multiple courses of antenatal steroids to mothers who were at risk for delivering prematurely. However, certain studies found that there were possible adverse affects to multiple ACS courses because babies were found to have slightly smaller head circumferences and lower birth weights. As a result the National Institutes of Health (NIH) recommended further study.

"The effect (of the NIH recommendation) was that doctors were only giving one ACS course, and they were nervous about when to give it for the best effect. They often waited until the last minute, and some women didn't get a complete treatment or didn't get it at all," said Dr. Kurtzman. "What this study has found is that we can give women who threaten to deliver prematurely an initial ACS course, and if they remain pregnant, we can give one 'rescue course' closer to delivery. By doing so, the babies' complications are reduced by about a third with no adverse side effects found."

In this study, which took place over five years in 18 different medical centers and was supported by the Pediatrix Medical Group, 437 patients were randomized (233 in the study group, and 214 in the placebo group). The results showed a significant reduction in composite neonatal morbidity for babies born prior to 34 weeks in the "rescue steroid" group vs. placebo (43.9% vs. 63.6%) as well as significant decrease in respiratory distress syndrome, ventilator support, and surfactant use. When all neonates were included in the analysis (regardless of the gestational age at delivery), a significant reduction in composite morbidity in the "rescue steroid" group was still demonstrated (32.1% vs. 42.6%).


'/>"/>

Contact: Vicki Bendure
vicki@bendurepr.com
202-374-9259
Society for Maternal-Fetal Medicine
Source:Eurekalert

Related biology news :

1. Brain structure assists in immune response, according to Penn vet study
2. Study finds MRSA in Midwestern swine, workers
3. New study provides further evidence that apple juice can delay onset of Alzheimers disease
4. UD research study to shed light on emerging seaborne pathogen
5. Study links water pollution with declining male fertility
6. UGA study may give hope that ivory-billed woodpeckers still around
7. Evolutionary process more detailed than previously believed, study shows
8. Researchers to use K-States BSL-3 Lab for $1 million study of fungus threatening wheat crops
9. Human beta cells can be easily induced to replicate, according to study in Diabetes
10. Primate culture is just a stones throw away from human evolution, study finds
11. Disabling enzyme allows mice to gorge without becoming obese, new study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/24/2017)... -- The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative high ... ... Maldives Immigration Controller ... (small picture on the right) have received the IAIR award for the ...
Breaking Biology News(10 mins):
(Date:9/21/2017)... ... 2017 , ... Vixiar Medical announced today that it will ... The LaunchPort™ Accelerator at the City Garage in Port Covington. The LaunchPort™, and ... services to its Residents. , Vixiar Medical recently closed a $1.5 million ...
(Date:9/21/2017)... ... (PRWEB) September 21, 2017 , ... The 3rd ... to review the latest knowledge on these products, which are increasingly used in ... the impact of Biostimulants on Plant Nutrition, Abiotic Stresses, Plant Growth and Development, ...
(Date:9/21/2017)... ... September 21, 2017 , ... Executives and ... world’s most progressive pharma and biotech organizations to do more clinical trials will ... biotech events in Q4. , DrugDev will demonstrate DrugDev Spark™, the world’s first ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... green this month, the response was swift and efficient thanks to the continuing ... RRWQG is made up of more than 50 stakeholders, including officials from area ...
Breaking Biology Technology: